<p>ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy.</p>

The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic stem cell transplantation (HSCT) for individuals with myelodysplastic syndromes (MDS) based on requests from ASH, ASTCT, NMDP, and CIBMTR.

The annual award honors Roberts’ special service to the patients and families that are served by the ASTCT community.

Live webinar explores how integrative multi-omic drug sensitivity data can improve drug development

Having two mutated copies of the TP53 gene - as opposed to a single mutated copy - is associated with worse outcomes in myelodysplastic syndrome and acute myeloid leukemia.

This important initiative will set the standard for global patient care in hemophilia

This important initiative will set the standard for global patient care in hemophilia

Improved cold chain management for blood and food products

The Expert Network© celebrates its newest member, Dr. Ashkan Lashkari

The Expert Network celebrates its newest member, Dr. Michel Vulfovich

The Expert Network celebrates its newest member, Dr. David J. Peace

Global Community of Leading Experts in the Fields of Thrombosis and Hemostasis Meet in France for First Time in 15 Years

Inaugural World Thrombosis Day Steering Committee Member to Represent Africa

The controversial devices are linked to at least 27 deaths and over 300 additional injuries. Many devices can become difficult or impossible to retrieve if left in for more than 30-45 days after implant.

Journal of Thrombosis and Haemostasis publishes article on first internationally developed and reviewed Core Curriculum to guide clinical knowledge and training in the industry